Novel Approaches for Oral Insulin Delivery - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Novel Approaches for Oral Insulin Delivery
The authors review various oral drug delivery systems that have been explored to increase patient compliance for insulin.


Pharmaceutical Technology
Volume 33, Issue 7

33. N. Zhang et al., "Investigation of Lectin-Modified Insulin Liposomes as Carriers for Oral Administration," Int. J. Pharm. 294 (1–2), 247–59 (2005).

34. M. Ramadas et al., "Lipoinsulin Encapsulated Alginate-Chitosan Capsules: Intestinal Delivery in Diabetic Rats," J. Microencapsul. 17 (4), 405–411 (2000).

35. D. Attivi et al., "Formulation of Insulin-Loaded Polymeric Nanoparticles using Response Surface Methodology," Drug Dev. Ind. Pharm. 31 (2), 179–189 (2005).

36. D.R. Bhumkar et al., "Chitosan-Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin," Pharm. Res. 23 (2007).

37. C. Damge et al., "Poly (alkyl cyanoacrylate) Nanospheres for Oral Adminiatration of Insulin," J Pharm Sci. 86 1403–1409 (1997).

38. C. Damge, P. Maincent, and N. Ubrich, "Oral Delivery of Insulin Associated to Polymeric Nanoparticles in Diabetic Rats," J Control Release 117 (2), 163–170, Epub 2006 (2007).

39. K.B. Chalasani et al., "A Novel Vitamin B12-Nanosphere Conjugate Carrier System for Peroral Delivery of Insulin," J Control Release 117 (3), 421–429 Epub 2006, (2007).

40. Y.H. Lin et al., "Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin Delivery," Biomacromolecules 8 (1), 146–152. (2007).

41. F.D. Cui et al., "Preparation of Insulin-Loaded PLGA-Hp55 Nanoparticles for Oral Delivery," J. Pharm Sci. 96 (2), 421–427. (2007).

42. B. Sarmento et al., "Development and Characterization of New Insulin Containing Polysaccharide Nanoparticles," Colloids Surf B. Biointerfaces 53 (2), 193–202, (2006).

43. W. Tiyaboonchai et al., "Insulin Containing Polyethylenimine-Dextran Sulfate Nanoparticles," Int. J. Pharm. 255 (1–2), 139–51 (2006).

44. M. Simon et al., "Nanosized Insulin-Complexes based on BioDegradable Amine-Modified Graft Polyesters Poly(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(l-lactic acid): Protection Against Enzymatic Degradation, Interaction with Caco-2 Cell Monolayers, Peptide Transport and Cytotoxicity," Eur. J. Pharm. Biopharm. 66 (2), 165–172 (2007).

45. H. Tozaki et al., "Enhanced Absorption of Insulin and (Asu(1,7))eel-calcitonin Using Novel Azopolymer-Coated Pellets for Colon-Specific Drug Delivery," J. Pharm. Sci. 90 (1), 89–97 (2001).

46. H. Ichikawa and Y. Fukumori, "Design of Nanohydrogel-Incorporated Microcapsules for Appropriate Controlled-Release of Peptide Drugs," Yakugaku Zasshi 127 (5), 813–823 (2007).

47. K. Whitehead, Z. Shen, and S. Mitragotri, "Oral Delivery of Macromolecules Using Intestinal Patches: Applications for Insulin Delivery," J. Control. Release 98 (1), 37–45 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here